Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab plus 5-FU/Leucovorin in Metastatic Colorectal Cancer
NCT00066846Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Aug 2003; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00066846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066846.